These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. A review of the safety of MRI in cochlear implant patients with retained magnets. Srinivasan R; So CW; Amin N; Jaikaransingh D; D'Arco F; Nash R Clin Radiol; 2019 Dec; 74(12):972.e9-972.e16. PubMed ID: 31324337 [TBL] [Abstract][Full Text] [Related]
64. [Vibrant Soundbridge®: An Alternative Hearing System for Preschool Children with Aural Atresia]. Leinung M; Zaretsky E; Ernst BP; Trier B; Stöver T; Hey C Laryngorhinootologie; 2016 Sep; 95(9):E1. PubMed ID: 27728919 [No Abstract] [Full Text] [Related]
65. Magnetic Resonance Imaging-Induced DNA Damage. Jaffer H; Murphy KJ Can Assoc Radiol J; 2017 Feb; 68(1):2-3. PubMed ID: 28117069 [No Abstract] [Full Text] [Related]
66. Emotional distress during magnetic resonance imaging. Flaherty JA; Hoskinson K N Engl J Med; 1989 Feb; 320(7):467-8. PubMed ID: 2913515 [No Abstract] [Full Text] [Related]
67. The sand-trap hazard in magnetic resonance imaging. Kim T; Vogelzang NJ Ann Intern Med; 1989 Feb; 110(3):243-4. PubMed ID: 2912364 [No Abstract] [Full Text] [Related]
68. Medical applications of nuclear magnetic resonance imaging. Margulis AR; Hricak H; Crooks L Q Rev Biophys; 1987 May; 19(3-4):221-37. PubMed ID: 3310080 [No Abstract] [Full Text] [Related]
75. Task force Guideline of Brazilian Society of Otology - hearing loss in children - Part II - Treatment. Silva VAR; Pauna HF; Lavinsky J; Hyppolito MA; Vianna MF; Leal M; Massuda ET; Hamerschmidt R; Bahmad F; Cal RV; Sampaio ALL; Felix F; Chone CT; Castilho AM Braz J Otorhinolaryngol; 2023; 89(1):190-206. PubMed ID: 36528468 [TBL] [Abstract][Full Text] [Related]
76. Active Middle Ear Implant in a Patient with Neurofibromatosis Type 1 and Multiple Calvarial Defects: A Case Report. Kajihara K; Ganaha A; Matsuda K; Nakamura T; Tono T J Int Adv Otol; 2022 Mar; 18(2):183-187. PubMed ID: 35418368 [TBL] [Abstract][Full Text] [Related]
77. Comparison of artefact reduction possibilities with the new active transcutaneous bone conduction implant (Bonebridge). Edlinger S; Tenner E; Frühwald J; Sprinzl G J Laryngol Otol; 2023 Mar; 137(3):263-269. PubMed ID: 35144697 [TBL] [Abstract][Full Text] [Related]
78. Two-phase survey on the frequency of use and safety of MRI for hearing implant recipients. van de Heyning P; Mertens G; Topsakal V; de Brito R; Wimmer W; Caversaccio MD; Dazert S; Volkenstein S; Zernotti M; Parnes LS; Staecker H; Bruce IA; Rajan G; Atlas M; Friedland P; Skarzynski PH; Sugarova S; Kuzovkov V; Hagr A; Mlynski R; Schmutzhard J; Usami SI; Lassaletta L; Gavilán J; Godey B; Raine CH; Hagen R; Sprinzl GM; Brown K; Baumgartner WD; Karltorp E Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4225-4233. PubMed ID: 33788034 [TBL] [Abstract][Full Text] [Related]
79. [MRI in patients with auditory implants equipped with implanted magnets-an update : Overview and procedural management]. Nospes S; Brockmann MA; Läßig A Radiologe; 2019 Jan; 59(1):48-56. PubMed ID: 30350108 [TBL] [Abstract][Full Text] [Related]
80. In vivo experiences with magnetic resonance imaging scans in Vibrant Soundbridge type 503 implantees. Todt I; Mittmann P; Ernst A; Mutze S; Rademacher G J Laryngol Otol; 2018 May; 132(5):401-403. PubMed ID: 29683103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]